RxDoctor Payments Data

Nickolas Garcia

Physician Assistant · San Antonio, TXNPI 1497155386

Payments from drug & device makers

$4,726in general payments, 2019–2025

Across 43 payments — averaging $109.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Radius Health, Inc.$4K
  • AbbVie$157
  • Lilly USA, LLC$146
  • Si-bone, Inc.$146
  • Revance Therapeutics, Inc.$75
  • Teva Pharmaceuticals USA, Inc.$17
  • plus $11 from 1 others

What the payments were for

  • Speaking & faculty fees$2,25048%
  • Travel & lodging$1,72537%
  • Food & beverage$75116%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,726 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$153,274
Medicare patients
355
Services billed
1,395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$24,629
EliquisApixaban77$22,462
TrulicityDulaglutide20$20,134
MyrbetriqMirabegron36$8,319
JardianceEmpagliflozin24$7,361
JanuviaSitagliptin Phosphate21$5,782
XareltoRivaroxaban17$4,848
NamzaricMemantine Hcl/Donepezil Hcl14$3,607
Duloxetine Hcl34$3,121
GemtesaVibegron12$2,899
Divalproex Sodium ErDivalproex Sodium12$1,123
Levothyroxine Sodium71$918
Colestipol Hcl12$744
Levetiracetam23$744
Esomeprazole Magnesium13$730

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$146$44,76441 claims
AbbVieNamzaric$157$3,60714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →